Cargando…

Triglyceride-glucose index, renal function and cardiovascular disease: a national cohort study

BACKGROUND: The triglyceride-glucose (TyG) index is a predictor of cardiovascular diseases; however, to what extent the TyG index is associated with cardiovascular diseases through renal function is unclear. This study aimed to evaluate the complex association of the TyG index and renal function wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Cancan, Liu, Lin, zhang, Te, Fang, Ling, Mo, Zhanhao, Qi, Yitian, Zheng, Jia, Wang, Zhijia, Xu, Haikun, Yan, Han, Yue, Siqi, Wang, Xuekui, Wu, Zhiyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685637/
https://www.ncbi.nlm.nih.gov/pubmed/38017519
http://dx.doi.org/10.1186/s12933-023-02055-4
_version_ 1785151678439227392
author Cui, Cancan
Liu, Lin
zhang, Te
Fang, Ling
Mo, Zhanhao
Qi, Yitian
Zheng, Jia
Wang, Zhijia
Xu, Haikun
Yan, Han
Yue, Siqi
Wang, Xuekui
Wu, Zhiyuan
author_facet Cui, Cancan
Liu, Lin
zhang, Te
Fang, Ling
Mo, Zhanhao
Qi, Yitian
Zheng, Jia
Wang, Zhijia
Xu, Haikun
Yan, Han
Yue, Siqi
Wang, Xuekui
Wu, Zhiyuan
author_sort Cui, Cancan
collection PubMed
description BACKGROUND: The triglyceride-glucose (TyG) index is a predictor of cardiovascular diseases; however, to what extent the TyG index is associated with cardiovascular diseases through renal function is unclear. This study aimed to evaluate the complex association of the TyG index and renal function with cardiovascular diseases using a cohort design. METHODS: This study included participants from the China Health and Retirement Longitudinal Study (CHARLS) free of cardiovascular diseases at baseline. We performed adjusted regression analyses and mediation analyses using Cox models. The TyG index was calculated as Ln [fasting triglyceride (mg/dL) × fasting glucose (mg/dL)/2]. Renal function was defined by the estimated glomerular filtration rate (eGFR). RESULTS: A total of 6 496 participants were included in this study. The mean age of the participants was 59.6 ± 9.5 years, and 2996 (46.1%) were females. During a maximum follow-up of 7.0 years, 1 996 (30.7%) people developed cardiovascular diseases, including 1 541 (23.7%) cases of heart diseases and 651 (10.0%) cases of stroke. Both the TyG index and eGFR level were significantly associated with cardiovascular diseases. Compared with people with a lower TyG index (median level) and eGFR ≥ 60 ml/minute/1.73 m(2), those with a higher TyG index and decreased eGFR had the highest risk of cardiovascular diseases (HR, 1.870; 95% CI 1.131–3.069). Decreased eGFR significantly mediated 29.6% of the associations between the TyG index and cardiovascular diseases. CONCLUSIONS: The combination of a higher TyG index and lower eGFR level was associated with the highest risk of cardiovascular diseases. Renal function could mediate the association between the TyG index and cardiovascular risk. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12933-023-02055-4.
format Online
Article
Text
id pubmed-10685637
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-106856372023-11-30 Triglyceride-glucose index, renal function and cardiovascular disease: a national cohort study Cui, Cancan Liu, Lin zhang, Te Fang, Ling Mo, Zhanhao Qi, Yitian Zheng, Jia Wang, Zhijia Xu, Haikun Yan, Han Yue, Siqi Wang, Xuekui Wu, Zhiyuan Cardiovasc Diabetol Research BACKGROUND: The triglyceride-glucose (TyG) index is a predictor of cardiovascular diseases; however, to what extent the TyG index is associated with cardiovascular diseases through renal function is unclear. This study aimed to evaluate the complex association of the TyG index and renal function with cardiovascular diseases using a cohort design. METHODS: This study included participants from the China Health and Retirement Longitudinal Study (CHARLS) free of cardiovascular diseases at baseline. We performed adjusted regression analyses and mediation analyses using Cox models. The TyG index was calculated as Ln [fasting triglyceride (mg/dL) × fasting glucose (mg/dL)/2]. Renal function was defined by the estimated glomerular filtration rate (eGFR). RESULTS: A total of 6 496 participants were included in this study. The mean age of the participants was 59.6 ± 9.5 years, and 2996 (46.1%) were females. During a maximum follow-up of 7.0 years, 1 996 (30.7%) people developed cardiovascular diseases, including 1 541 (23.7%) cases of heart diseases and 651 (10.0%) cases of stroke. Both the TyG index and eGFR level were significantly associated with cardiovascular diseases. Compared with people with a lower TyG index (median level) and eGFR ≥ 60 ml/minute/1.73 m(2), those with a higher TyG index and decreased eGFR had the highest risk of cardiovascular diseases (HR, 1.870; 95% CI 1.131–3.069). Decreased eGFR significantly mediated 29.6% of the associations between the TyG index and cardiovascular diseases. CONCLUSIONS: The combination of a higher TyG index and lower eGFR level was associated with the highest risk of cardiovascular diseases. Renal function could mediate the association between the TyG index and cardiovascular risk. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12933-023-02055-4. BioMed Central 2023-11-28 /pmc/articles/PMC10685637/ /pubmed/38017519 http://dx.doi.org/10.1186/s12933-023-02055-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Cui, Cancan
Liu, Lin
zhang, Te
Fang, Ling
Mo, Zhanhao
Qi, Yitian
Zheng, Jia
Wang, Zhijia
Xu, Haikun
Yan, Han
Yue, Siqi
Wang, Xuekui
Wu, Zhiyuan
Triglyceride-glucose index, renal function and cardiovascular disease: a national cohort study
title Triglyceride-glucose index, renal function and cardiovascular disease: a national cohort study
title_full Triglyceride-glucose index, renal function and cardiovascular disease: a national cohort study
title_fullStr Triglyceride-glucose index, renal function and cardiovascular disease: a national cohort study
title_full_unstemmed Triglyceride-glucose index, renal function and cardiovascular disease: a national cohort study
title_short Triglyceride-glucose index, renal function and cardiovascular disease: a national cohort study
title_sort triglyceride-glucose index, renal function and cardiovascular disease: a national cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685637/
https://www.ncbi.nlm.nih.gov/pubmed/38017519
http://dx.doi.org/10.1186/s12933-023-02055-4
work_keys_str_mv AT cuicancan triglycerideglucoseindexrenalfunctionandcardiovasculardiseaseanationalcohortstudy
AT liulin triglycerideglucoseindexrenalfunctionandcardiovasculardiseaseanationalcohortstudy
AT zhangte triglycerideglucoseindexrenalfunctionandcardiovasculardiseaseanationalcohortstudy
AT fangling triglycerideglucoseindexrenalfunctionandcardiovasculardiseaseanationalcohortstudy
AT mozhanhao triglycerideglucoseindexrenalfunctionandcardiovasculardiseaseanationalcohortstudy
AT qiyitian triglycerideglucoseindexrenalfunctionandcardiovasculardiseaseanationalcohortstudy
AT zhengjia triglycerideglucoseindexrenalfunctionandcardiovasculardiseaseanationalcohortstudy
AT wangzhijia triglycerideglucoseindexrenalfunctionandcardiovasculardiseaseanationalcohortstudy
AT xuhaikun triglycerideglucoseindexrenalfunctionandcardiovasculardiseaseanationalcohortstudy
AT yanhan triglycerideglucoseindexrenalfunctionandcardiovasculardiseaseanationalcohortstudy
AT yuesiqi triglycerideglucoseindexrenalfunctionandcardiovasculardiseaseanationalcohortstudy
AT wangxuekui triglycerideglucoseindexrenalfunctionandcardiovasculardiseaseanationalcohortstudy
AT wuzhiyuan triglycerideglucoseindexrenalfunctionandcardiovasculardiseaseanationalcohortstudy